Rapid antigen tests for SARS-CoV-2
- PMID: 33658245
- PMCID: PMC8099168
- DOI: 10.1503/cmaj.202827
Rapid antigen tests for SARS-CoV-2
Conflict of interest statement
Competing interests: Mel Krajden has received grants paid to his institution from Roche, Hologic and Siemens, outside the submitted work. No other competing interests were declared.
Comment in
-
Rapid antigen screening of asymptomatic people as a public health tool to combat COVID-19.CMAJ. 2021 Mar 29;193(13):E449-E452. doi: 10.1503/cmaj.210100. Epub 2021 Mar 2. CMAJ. 2021. PMID: 33658247 Free PMC article. No abstract available.
Comment on
-
Rapid antigen screening of asymptomatic people as a public health tool to combat COVID-19.CMAJ. 2021 Mar 29;193(13):E449-E452. doi: 10.1503/cmaj.210100. Epub 2021 Mar 2. CMAJ. 2021. PMID: 33658247 Free PMC article. No abstract available.
References
-
- Priority strategies to optimize testing and screening for COVID-19 in Canada: Report. Ottawa: Government of Canada; 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous